Description of Collaborative Activity: |
The National Institutes of Health (NIH) Biomarkers Consortium develops, validates, and qualifies biological markers (biomarkers) to speed the development of medicines and therapies for detection, prevention, diagnosis, and treatment of disease and to improve patient care. The Foundation for the National Institutes of Health (FNIH) coordinates and manages NIH participation in the consortium. The consortium encompasses research projects, ongoing working groups, as well as occasional workshops and conferences. |
NIH Participating Institutes/Centers/Office of the Director: |
NCATS, NCI, NEI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDDK, NIEHS, NIMH, NINDS |
